Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 4/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | HPGD | P15428 | 4/20 | 0.57 |
| ▸ | NPC1 | O15118 | 4/20 | 0.57 |
| ▸ | RAB9A | P51151 | 4/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.57 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.57 |
| ▸ | RELA | Q04206 | 2/20 | 0.57 |
| ▸ | PKM | P14618 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL828491 | 0.88 | TSHR (0.67) | MAPK1HPGDNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1189145 | 0.85 | NPC1 (0.63) | ALDH1A1MAPK1MEN1KMT2AHPGD | |
| SCHEMBL4824941 | 0.83 | SRD5A2 (0.82) | ALDH1A1MAPK1SRD5A2MEN1KMT2A | |
| SCHEMBL28705388 | 0.83 | ALDH1A1 (0.62) | ALDH1A1MAPK1SRD5A2MEN1KMT2A | |
| SCHEMBL2601929 | 0.83 | ALDH1A1 (0.74) | ALDH1A1MAPK1SRD5A2MEN1KMT2A | |
| SCHEMBL18101244 | 0.83 | KDM4E (0.70) | ALDH1A1KMT2AHPGDNPC1RAB9A | |
| SCHEMBL18101284 | 0.83 | KDM4E (0.70) | ALDH1A1KMT2AHPGDNPC1RAB9A | |
| SCHEMBL18101240 | 0.83 | KDM4E (0.70) | ALDH1A1KMT2AHPGDNPC1RAB9A | |
| SCHEMBL18101248 | 0.83 | KDM4E (0.70) | ALDH1A1KMT2AHPGDNPC1RAB9A | |
| SCHEMBL10441519 | 0.82 | MEN1 (0.61) | ALDH1A1MAPK1SRD5A2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 837 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552931-B2 | Dihydroxy lactam based polymers, compositions and applications thereof | ISP INVESTMENTS LLC (US) | 2026-02-17 | — | — | US | claimed |
| US-20220315761-A1 | DIHYDROXY LACTAM BASED POLYMERS, COMPOSITIONS AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2022-10-06 | — | — | US | claimed |
| CN-101775084-B | Method for preparing organic-dissolvable photosensitive chitosan derivate | CHANGZHOU INST OF ADVANCED MATERIALS BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY | 2011-11-09 | — | — | CN | claimed |
| CN-101781375-A | Preparation method of organic soluble photosensitive chitosan derivative | CHANGZHOU INST OF ADVANCED MAT | 2010-07-21 | — | — | CN | claimed |
| CN-101775084-A | Method for preparing organic-dissolvable photosensitive chitosan derivate | UNIV BEIJING CHEMICAL | 2010-07-14 | — | — | CN | claimed |
| US-20070202612-A1 | Plasma-Polymerisation Of Polycylic Compounds | FORSKININGSCENTER RISO | 2007-08-30 | — | — | US | claimed |
| WO-2005092521-A2 | PLASMA-POLYMERISATION OF POLYCYCLIC COMPOUNDS | Forskningscenter Risø (DK) | 2005-10-06 | — | — | WO | claimed |
| EP-4713018-A1 | TRANSFECTION COMPOSITIONS SUITABLE FOR PRODUCING A BIOLOGICAL PRODUCT | PolyPlus Transfection (FR) | 2026-03-25 | — | — | EP | disclosed |
| US-12552931-B2 | Dihydroxy lactam based polymers, compositions and applications thereof | ISP INVESTMENTS LLC (US) | 2026-02-17 | — | — | US | disclosed |
| US-12384778-B2 | Pyrazolopyridine compounds and uses thereof | INCYTE CORPORATION (US) | 2025-08-12 | — | — | US | disclosed |
| WO-2025098545-A1 | NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST CORONAVIRUSES | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I. (CZ) | 2025-05-15 | — | — | WO | disclosed |
| EP-4553080-A1 | NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST CORONAVIRUSES | Ustav Organicke Chemie a Biochemie AV CR, v.v.i. (CZ) | 2025-05-14 | — | — | EP | disclosed |
| US-20250057802-A1 | BROAD-SPECTRUM ANTIVIRAL DRUGS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-02-20 | — | — | US | disclosed |
| EP-0058435-A2 | Novel 4-aroylimidazol-2-ones | MERRELL DOW PHARMACEUTICALS INC. (US) | 1982-08-25 | — | — | EP | disclosed |
| US-4325873-A | Process for the preparation of styryl-cyclopropanecarboxylic acid esters and intermediate products for this process | BAYER AKTIENGESELLSCHAFT (DE) | 1982-04-20 | — | — | US | disclosed |
| US-4267174-A | AND PROCESS FOR ADMINISTERING | BOEHRINGER MANNHEIM, GMBH (DE) | 1981-05-12 | — | — | US | disclosed |
| US-4260774-A | IMMUNOSUPPRESSANTS, ANTITUMOR | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-04-07 | — | — | US | disclosed |
| EP-0018531-A1 | Substituted 2,2-dimethylpentane (ene)-1-carboxylic acid derivatives, process for their preparation and their use for the preparation of styryl-cyclopropane-carboxylates | BAYER AG (DE) | 1980-11-12 | — | — | EP | disclosed |
| US-4009208-A | N,N'-HEPTAMETHYLENEBIS(4-METHOXYBENZAMIDE) | STERLING DRUG INC. (US) | 1977-02-22 | — | — | US | disclosed |
| US-3987059-A | ALKYL LITHIUM, CYCLIZATION, DEMETALLIZATION | SANDOZ, INC. (US) | 1976-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12384778-B2 | Pyrazolopyridine compounds and uses thereof | PDXK, PCK1, PGK1 | ALDH1A1 2205/4885MAPK1 639/4885SRD5A2 1333/4885 |
| US-20250057802-A1 | BROAD-SPECTRUM ANTIVIRAL DRUGS | MAVS, EIF2AK2, ZC3HAV1 | ALDH1A1 3273/4885MAPK1 4668/4885SRD5A2 3429/4885 |
| US-12552931-B2 | Dihydroxy lactam based polymers, compositions and applications thereof | PARG, GNE, PGLS | ALDH1A1 235/4885MAPK1 4476/4885SRD5A2 1283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.